FDAnews
www.fdanews.com/articles/81977-sinovac-receives-gmp-certification-for-its-seasonal-influenza-vaccine-anflu-tm

SINOVAC RECEIVES GMP CERTIFICATION FOR ITS SEASONAL INFLUENZA VACCINE, ANFLU'TM'

October 27, 2005

Sinovac Biotech Ltd. (AMEX:SVA), a leading Chinese biotechnology company in vaccine development and marketing, has announced that the State Food and Drug Administration (SFDA) issued a GMP (Good Manufacturing Practices) certificate for Sinovac's proprietary influenza flu vaccine, AnfluTM. The GMP certificate is the final approval required to sell AnfluTM vaccine in China (PRC).

CCNMatthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=564680)